Biotechnology Stocks II: Compare Returns of S&P 500 to UroGen Pharma Ltd. (URGN)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
Compare Returns for S&P 500 and URGN | ||
---|---|---|
S&P 500 | URGN | |
Start Date | Jul-01-2017 | Jun-30-2017 |
Start Price | $2,800.75 | $18.06 |
End Date | Apr-11-2025 | Apr-17-2025 |
End Price | $5,363.36 | $9.67 |
Number Monthly Prices | 95 | 95 |
Min Date | Aug-01-2017 | May-31-2022 |
Min Price | $3,154.97 | $5.32 |
Max Date | Dec-01-2024 | May-31-2018 |
Max Price | $6,010.09 | $60.12 |
Total Return | 69.64% | -46.46% |
Annualized Return | 6.90% | -7.59% |
Current Value of $1,000 Purchase | $1,696 | $535 |
Number Returns | 4,465 | 4,465 |
Average Return | 22.87% | -28.19% |
Minimum Return | -25.54% | -91.15% |
Maximum Return | 90.50% | 307.14% |
Number Profitable Returns | 3,849 | 892 |
Percent Profitable Returns | 86.20% | 19.98% |
Number Unprofitable Returns | 616 | 3,573 |
Percent Unprofitable Returns | 13.80% | 80.02% |
Profitable to Unprofitable Returns Ratio | 6.25 | 0.25 |
URGN Dollar-cost Average
URGN Trendline Chart
URGN Moving Average Chart
URGN Stock Return Map - See Patterns of Gains and Losses
URGN Stock Returns/Purchase Dates